
[Congressional Bills 109th Congress]
[From the U.S. Government Printing Office]
[H.R. 5416 Introduced in House (IH)]








109th CONGRESS
  2d Session
                                H. R. 5416

 To provide for grants to conduct research toward the development of a 
                     vaccine against Valley Fever.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 18, 2006

  Mr. Thomas introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To provide for grants to conduct research toward the development of a 
                     vaccine against Valley Fever.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Valley Fever Vaccine Development 
Act''.

SEC. 2. GRANTS FOR RESEARCH ON VACCINE AGAINST VALLEY FEVER.

    (a) In General.--In supporting research on the development of 
vaccines against human diseases, the Secretary of Health and Human 
Services, acting through the Director of the Centers for Disease 
Control and Prevention, shall make grants for the purpose of conducting 
research toward the development of a vaccine against coccidioidomycosis 
(commonly known as Valley Fever).
    (b) Sunset.--No grant may be made under subsection (a) on or after 
October 1, 2012. The preceding sentence does not have any legal effect 
on payments under grants for which amounts appropriated under 
subsection (c) were obligated prior to such date.
    (c) Authorization of Appropriations.--For the purpose of making 
grants under subsection (a), there are authorized to be appropriated 
such sums as may be necessary for each of the fiscal years 2007 through 
2012.
                                 <all>
